National Institute on Disability and Rehabilitation Research (NIDRR)--Advanced Rehabilitation Research Training (ARRT) Projects

The summary for the National Institute on Disability and Rehabilitation Research (NIDRR)--Advanced Rehabilitation Research Training (ARRT) Projects grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Headquarters and Regional Offices, which is the U.S. government agency offering this grant.

National Institute on Disability and Rehabilitation Research (NIDRR)--Advanced Rehabilitation Research Training (ARRT) Projects: Note: Each funding opportunity description is a synopsis of information in the Federal Register application notice. For specific information about eligibility, please see the official application notice. The official version of this document is the document published in the Federal Register. Free Internet access to the official edition of the Federal Register and the Code of Federal Regulations is available on GPO Access at: http://www.access.gpo.gov/nara/index.html. Purpose of Program: The purpose of this program is to provide research training and experience at an advanced level to individuals with doctorates or similar advanced degrees who have clinical or other relevant experience. ARRT projects train rehabilitation researchers, including individuals with disabilities, with particular attention to research areas that support the implementation and objectives of the Rehabilitation Act of 1973, as amended (Act), and that improve the effectiveness of services authorized under the Act. Catalog of Federal Domestic Assistance (CFDA) Number: 84.133P.